WO2016196644A1 Substituted pyrazole and pyrrole compounds and methods for using them for inhibition of initiation of translation and treatment of diseases and disorders relating thereto
WO2018102453 Substituted pyrazole compounds and methods of using them for treatment of hyperproliferative diseases
WO2018102452 Methods of using substituted pyrazole and pyrazole compounds and for treatment of hyperproliferative diseases
WO2019236966 Methods of treatment of cancer with substituted pyrrole and pyrazole compounds and diagnosis of cancers susceptible to treatment with substituted pyrrole and pyrazole compounds
US20190345152A1 Substituted pyrazole compounds and methods of using them for treatment of hyperproliferative diseases
Crystalline polymorphs of a 1-thiazol-2-yl-pyrazole-5-carboxylic acid derivative
WO2020243582 Methods for making thiazolylpyrazole carboxylic acids and intermediates therefor
US10537558 Substituted pyrazole and pyrrole compounds and methods for using them for inhibition of initiation of translation and treatment of diseases and disorders relating to WO2020243584
Current patent estate covers Composition of Matter and Use Claims for Candidate and Back-ups, PR&D and crystalline form, combination therapies and companion diagnostics
We are an early mover in the field of mitochondrial homeostasis, using our pioneering science and unrivaled expertise in mitochondrial cellular biology to revolutionize oncology
We are seeking partners and additional investors to accelerate our clinical research and help bring novel cancer therapies closer to patients in need
Bantam is seeking partners and investors to drive rapid clinical development of our first-in-class molecule from First in Humans trials to clinical Proof of Concept.
